_(1).jpg)
SS&C Technologies Holdings unveiled a comprehensive suite of next-generation solutions at its annual Deliver 2025 conference, attended by nearly 1,200 leaders from the financial services and healthcare industries. The event highlighted SS&C's strategic focus on reimagining operations through AI, intelligent automation, and data-driven platforms, including the first official showcase of the recently acquired SS&C Calastone.
SS&C unveiled new AI and automation solutions at its Deliver 2025 conference.
Key announcements included a catalogue of pre-built AI agents for finance and healthcare.
The newly integrated SS&C Calastone global funds network was a central focus.
New platforms for drug management (DomaniRx) and alternative investments (Insights) were launched.
The company emphasized being "Customer Zero," testing technologies internally first.
The event underscored a strategy of engineering for measurable client outcomes.
A pivotal theme was the integration of SS&C Calastone, which connects over 4,500 financial organizations globally. This acquisition solidifies SS&C's position as a highly connected fintech provider, aiming to reduce friction in fund transactions and enhance transparency. The conference also served as the launchpad for several new data and analytics platforms, including SS&C Insights for alternative investments and SS&C WalletShare for distribution optimization, all designed to create a more unified financial ecosystem.
A significant portion of the innovations centered on practical AI applications. SS&C introduced a catalogue of pre-built AI agents, delivered as a managed service, to help organizations overcome talent shortages and operational bottlenecks securely. This enterprise-grade approach is supported by the AI Gateway governance platform. The company's strategy is informed by its own experience as "Customer Zero," where it first proved the efficiency gains of these technologies within its own operations before offering them to clients.
The new solutions extend deeply into healthcare and wealth management. The DomaniRx Drug Management Module modernizes drug management by integrating payer, pharmacy, and provider data, potentially reducing authorization delays by up to 70%. For wealth managers, SS&C Black Diamond® Wealth Solutions combines its award-winning platform with a full suite of operational services, while new Gen AI capabilities are being applied to retirement plan support and customer service.
The announcements at Deliver 2025 collectively signal SS&C's commitment to moving beyond traditional software to delivering outcome-focused, intelligent platforms. By leveraging its vast data resources and internal proof-of-concepts, the company is positioning itself to help clients in highly regulated industries achieve greater efficiency, scalability, and data-driven decision-making.
SS&C is a global provider of services and software for the financial services and healthcare industries. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices around the world. More than 23,000 financial services and healthcare organizations, from the world's largest companies to small and mid-market firms, rely on SS&C for expertise, scale, and technology.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.